Skip to main content
Clinical Trials/JPRN-UMIN000038984
JPRN-UMIN000038984
Completed
未知

Evaluation of the muscular hypertrophy effects of long-term using electrical muscle stimulation (EMS) devices: A randomized open-label parallel-group trial - Evaluation of the muscular hypertrophy effects of long-term using electrical muscle stimulation (EMS) devices

ORTHOMEDICO Inc.0 sites102 target enrollmentDecember 25, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Healthy subjects
Sponsor
ORTHOMEDICO Inc.
Enrollment
102
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 25, 2019
End Date
March 21, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Subjects who are undergoing medical treatment or have a medical history of malignant tumor, heart failure, or myocardial infarction 2\. Subjects who have a cardiac disorder or potential one 3\. Subjects who have a pacemaker or an implantable cardioverter defibrillator (ICD) 4\. Subjects who have a metal such as a joint prosthesis, clips, and so on. 5\. Currently undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases 6\. Subjects who have a wound on the skin of the target part 7\. Subjects who have been diagnosed with epilepsy 8\. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily 9\. Subjects who are currently taking food and supplements affecting muscular hypertrophy such as protein, amino acids, and 3\-Hydroxy 3\-MethylButyrate (HMB) 10\. Subjects who have exercise habits or muscular workouts more than two times per week 11\. Subjects who are required to be placed at rest 12\. Subjects who have an acute painful disease such as spine fractures, sprains, and flesh breaks 13\. Currently taking medicines (include herbal medicines) and supplements 14\. Subjects who have metal allergy 15\. Subjects who cannot understand the method of application of test device 16\. Subjects who are pregnant, breast\-feeding, and planning to become pregnant 17\. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial or plan to participate another trial during this trial 18\. Subjects who are judged as ineligible to participate in the study by the physician

Outcomes

Primary Outcomes

Not specified

Similar Trials